Among GM-targeted interventions, dietary modification, metabolic bariatric surgery, and incretin-based pharmacotherapy demonstrate the most consistent and clinically meaningful metabolic benefits, with observed GM changes likely representing downstream mediators rather than primary drivers of these effects
Ozempic, Wegovy, Mounjaro, and Saxenda represent exciting advances in the management of diabetes and obesity
Handbook of Clinical Neurology, 156, 431443
A research study in rats reported that another GLP-1 medication with similar effects to tirzepatide, Saxenda (liraglutide), lowered wakefulness and modified the rats sleep patterns
My weight loss made me look 10 years younger no Botox needed, she told NeedToKnow
Written informed consent was obtained from all patients